Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ridker, P. M.
space
  arrow  Shih, J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Baseline IgG Antibody Titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes Simplex Virus, and Cytomegalovirus and the Risk for Cardiovascular Disease in Women

right arrow Paul M. Ridker, MD; Charles H. Hennekens, MD; Julie E. Buring, ScD; Ruth Kundsin, PhD; and Jessie Shih, PhD

19 October 1999 | Volume 131 Issue 8 | Pages 573-577

Background: Results of cross-sectional and retrospective studies have suggested that chronic infection may be a risk factor for cardiovascular disease. However, prospective data evaluating the relation between baseline antibody titers against various plausible agents and risk for cardiovascular disease are sparse, particularly among women.

Objective: To determine whether previous exposure to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, or cytomegalovirus is associated with increased risk for cardiovascular events.

Design: Prospective, nested, case–control study.

Setting: Women's Health Study.

Participants: Apparently healthy postmenopausal women.

Measurements: IgG antibody titers against C. pneumoniae, H. pylori, herpes simplex virus, and cytomegalovirus were measured in baseline blood samples obtained from 122 study participants who subsequently reported a first cardiovascular event (case-patients) and 244 participants matched for age and smoking status who did not report a cardiovascular event (controls) during 3 years of follow-up.

Results: Little evidence was found of an association between risk for cardiovascular events and baseline IgG seropositivity for antibodies against C. pneumoniae (rate ratio, 1.1 [95% CI, 0.7 to 1.8]), H. pylori (rate ratio, 0.90 [CI, 0.6 to 1.4]), herpes simplex virus (rate ratio, 1.2 [CI, 0.6 to 2.1]), and cytomegalovirus (rate ratio, 0.9 [CI, 0.6 to 1.5]). In addition, there was little evidence of an association between a participant's total number of infections and subsequent cardiovascular risk (P > 0.2).

Conclusion: In apparently healthy postmenopausal women, little evidence was found that previous infection, as measured by IgG antibody titers to C. pneumoniae, H. pylori, herpes simplex virus, and cytomegalovirus, is associated with subsequent risk for cardiovascular disease.

Author and Article Information
space

From Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; and Abbott Laboratories, Abbott Park, Illinois.

Grant Support: By the National Heart, Lung, and Blood Institute (HL58755) and by an Established Investigator Award from the American Heart Association (Dr. Ridker).

Requests for Reprints: Paul M. Ridker, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115. For reprint orders in quantities exceeding 100, please contact the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.

Current Author Addresses: Dr. Ridker: Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115.

Drs. Hennekens, Buring, and Kundsin: Department of Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215.

Dr. Shih: Abbott Laboratories, D-9FS AP20, 100 Abbott Park Road, Abbott Park, IL 60064-6015.


Related articles in Annals:

Summaries for Patients
Chronic Infection and the Risk for Heart Disease
Annals 1999 131: 573. [Full Text]  

Letters
Chronic Infection and Coronary Risk
Michael Mogadam
Annals 2000 132: 842. [Full Text]  



This article has been cited by other articles:


Home page
HeartHome page
A Steptoe, A Shamaei-Tousi, A Gylfe, B Henderson, S Bergstrom, and M Marmot
Socioeconomic status, pathogen burden and cardiovascular disease risk
Heart, December 1, 2007; 93(12): 1567 - 1570.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. L. Herne, R. Talpur, J. Breuer-McHam, R. Champlin, and M. Duvic
Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sezary syndrome
Blood, March 15, 2003; 101(6): 2132 - 2135.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Liuba, J. Persson, J. Luoma, S. Yla-Herttuala, and E. Pesonen
Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media
Eur. Heart J., March 2, 2003; 24(6): 515 - 521.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. J. Angiolillo, G. Liuzzo, S. Pelliccioni, E. De Candia, R. Landolfi, F. Crea, A. Maseri, and L. M. Biasucci
Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina
J. Am. Coll. Cardiol., February 19, 2003; 41(4): 546 - 550.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Smieja, J. Gnarpe, E. Lonn, H. Gnarpe, G. Olsson, Q. Yi, V. Dzavik, M. McQueen, S. Yusuf, and for the Heart Outcomes Prevention Evaluation (HOPE
Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
Circulation, January 21, 2003; 107(2): 251 - 257.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Prasad, J. Zhu, J. P.J. Halcox, M. A. Waclawiw, S. E. Epstein, and A. A. Quyyumi
Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction
Circulation, July 9, 2002; 106(2): 184 - 190.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Huittinen, M. Leinonen, L. Tenkanen, M. Manttari, H. Virkkunen, T. Pitkanen, E. Wahlstrom, T. Palosuo, V. Manninen, and P. Saikku
Autoimmunity to Human Heat Shock Protein 60, Chlamydia pneumoniae Infection, and Inflammation in Predicting Coronary Risk
Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 431 - 437.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Tavendale, D. Parratt, S.D. Pringle, R. A'brook, and H. Tunstall-Pedoe
Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events. The Scottish Heart Health Study Cohort
Eur. Heart J., February 2, 2002; 23(4): 301 - 307.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
J. Boman and M. R. Hammerschlag
Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies
Clin. Microbiol. Rev., January 1, 2002; 15(1): 1 - 20.
[Abstract] [Full Text]


Home page
CirculationHome page
P. M. Ridker
On Evolutionary Biology, Inflammation, Infection, and the Causes of Atherosclerosis
Circulation, January 1, 2002; 105(1): 2 - 4.
[Full Text] [PDF]


Home page
CirculationHome page
C. Espinola-Klein, H. J. Rupprecht, S. Blankenberg, C. Bickel, H. Kopp, G. Rippin, A. Victor, G. Hafner, W. Schlumberger, and J. Meyer
Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis
Circulation, January 1, 2002; 105(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. C. Johnston, L. M. Messina, W. S. Browner, M. T. Lawton, C. Morris, and D. Dean
C-Reactive Protein Levels and Viable Chlamydia pneumoniae in Carotid Artery Atherosclerosis
Stroke, December 1, 2001; 32(12): 2748 - 2752.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. J. Blake and P. M. Ridker
Novel Clinical Markers of Vascular Wall Inflammation
Circ. Res., October 26, 2001; 89(9): 763 - 771.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. U. Heuschmann, D. Neureiter, M. Gesslein, B. Craiovan, M. Maass, G. Faller, G. Beck, B. Neundoerfer, and P. L. Kolominsky-Rabas
Association Between Infection With Helicobacter pylori and Chlamydia pneumoniae and Risk of Ischemic Stroke Subtypes: Results From a Population-Based Case-Control Study
Stroke, October 1, 2001; 32(10): 2253 - 2258.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. J. Rupprecht, S. Blankenberg, C. Bickel, G. Rippin, G. Hafner, W. Prellwitz, W. Schlumberger, and J. Meyer
Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease
Circulation, July 3, 2001; 104(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Schumacher, A. B. Lerkerød, I. Seljeflot, L. Sommervoll, I. Holme, J. E. Otterstad, and H. Arnesen
Chlamydia pneumoniae Serology: Importance of Methodology in Patients with Coronary Heart Disease and Healthy Individuals
J. Clin. Microbiol., May 1, 2001; 39(5): 1859 - 1864.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
M. Smieja, S. Chong, M. Natarajan, A. Petrich, L. Rainen, and J. B. Mahony
Circulating Nucleic Acids of Chlamydia pneumoniae and Cytomegalovirus in Patients Undergoing Coronary Angiography
J. Clin. Microbiol., February 1, 2001; 39(2): 596 - 600.
[Abstract] [Full Text]


Home page
CirculationHome page
P. K. Shah
Link Between Infection and Atherosclerosis: Who Are The Culprits: Viruses, Bacteria, Both, or Neither?
Circulation, January 2, 2001; 103(1): 5 - 6.
[Full Text] [PDF]


Home page
CirculationHome page
J. Zhu, F. J. Nieto, B. D. Horne, J. L. Anderson, J. B. Muhlestein, and S. E. Epstein
Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death
Circulation, January 2, 2001; 103(1): 45 - 51.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. S. Siscovick, S. M. Schwartz, L. Corey, J. T. Grayston, R. Ashley, S.-P. Wang, B. M. Psaty, R. P. Tracy, L. H. Kuller, and R. A. Kronmal
Chlamydia pneumoniae, Herpes Simplex Virus Type 1, and Cytomegalovirus and Incident Myocardial Infarction and Coronary Heart Disease Death in Older Adults : The Cardiovascular Health Study
Circulation, November 7, 2000; 102(19): 2335 - 2340.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, Y.-k. Wong, M. Bernardes-Silva, M. Ward, and R. West
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis Commentary: Adjustment for potential confounders may have been taken too far
BMJ, July 22, 2000; 321(7255): 208 - 213.
[Abstract] [Full Text]


Home page
StrokeHome page
M. S. V. Elkind, I-F. Lin, J. T. Grayston, and R. L. Sacco
Chlamydia pneumoniae and the Risk of First Ischemic Stroke : The Northern Manhattan Stroke Study
Stroke, July 1, 2000; 31(7): 1521 - 1525.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
N. Engl. J. Med., March 23, 2000; 342(12): 836 - 843.
[Abstract] [Full Text] [PDF]


Home page
JWatch Infect. DiseasesHome page
Infections and Cardiovascular Disease in Women
Journal Watch Infectious Diseases, January 1, 2000; 2000(101): 13 - 13.
[Full Text]


Home page
JWatch GeneralHome page
Is Heart Disease Infectious or Not?
Journal Watch (General), October 29, 1999; 1999(1029): 2 - 2.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1999 by the American College of Physicians.